@article{oai:repository.lib.tottori-u.ac.jp:00004760,
 author = {藤原, 和典 and Fujiwara, Kazunori and 福原, 隆宏 and Fukuhara, Takahiro and 小山, 哲史 and Koyama, Satoshi and 竹内, 裕美 and Takeuchi, Hiromi and Taira, Kenkichiro and Morisaki, Tsuyoshi and Donishi, Ryohei},
 issue = {4},
 journal = {Yonago Acta Medica, Yonago Acta Medica},
 month = {Nov},
 note = {Cetuximab is an effective drug used to treat patients with recurrent or metastatic head and neck squamous cell carcinoma. Skin toxicities such as paronychia and skin exsiccation are common adverse events caused by cetuximab. Skin toxicities may cause significant physical and psychosocial discomfort. The goal of managing skin toxicities is to minimize the detrimental effects on quality of life and continue the treatment. In one patient, skin toxicities became severe, up to grade 2, during treatment. The pain induced by paronychia and skin exsiccation made daily life difficult. Ten days after starting Unseiin, symptoms and finger findings resolved significantly. The patient could resume daily activities. No adverse effects induced by Unseiin were observed during treatment. Unseiin was effective on paronychia and skin exsiccation in this case and may contribute to successful treatment of skin toxicities induced by cetuximab.},
 pages = {379--384},
 title = {Unseiin, a Kampo medicine, Reduces the Severity and Manifestations of Skin Toxicities Induced by Cetuximab: A Case Report},
 volume = {63},
 year = {2020},
 yomi = {フジワラ, カズノリ and フクハラ, タカヒロ and コヤマ, サトシ and タケウチ, ヒロミ}
}